A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly

Clinical trial NCT06082843 · TERMINATED

Trial details

NCT number: NCT06082843
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Portal Liver Cirrhosis

Start date: 2024-01-03
Primary completion: 2024-05-30
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.